ANTHONY MARESSO to Phage Therapy
This is a "connection" page, showing publications ANTHONY MARESSO has written about Phage Therapy.
Connection Strength
5.032
-
Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
Score: 0.914
-
Phage-induced protection against lethal bacterial reinfection. Proc Natl Acad Sci U S A. 2025 Jun 03; 122(22):e2423286122.
Score: 0.897
-
The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024 Dec 12; 12(1):eesp00292023.
Score: 0.815
-
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin Infect Dis. 2023 10 13; 77(8):1079-1091.
Score: 0.801
-
Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
Score: 0.697
-
Present and future of microbiome-targeting therapeutics. J Clin Invest. 2025 Jun 02; 135(11).
Score: 0.224
-
Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother. 2022 03 15; 66(3):e0207121.
Score: 0.178
-
Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy. J Surg Res. 2022 03; 271:73-81.
Score: 0.176
-
Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli. mBio. 2021 04 27; 12(2).
Score: 0.169
-
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020 08 04; 11(4).
Score: 0.161